Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue

Submit an article Journal homepage

Open access

106

Views

CrossRef citations to date

Altmetric

Original Research

Symptomatic burden of COPD for patients receiving dual or triple therapy

Stephanie Chen1 Health Economics and Payer Analytics, AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]

Mark Small2 Respiratory, Adelphi Real World, Bollington, UK

Leandro Lindner3 Global Payer Evidence and Pricing, AstraZeneca, Cambridge, UK

Xiao Xu1 Health Economics and Payer Analytics, AstraZeneca, Gaithersburg, MD, USA;4 Global Payer Evidence and Pricing, AstraZeneca, Gaithersburg, MD, USA

Pages 1365-1376 | Published online: 27 Apr 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Lopez-CamposJLTanWSorianoJBGlobal burden of COPDRespirology2016211142326494423
PubMed Web of Science ®Google Scholar
GOLD [webpage on the Internet]GOLD 2018 Global Strategy for the Diagnosis, Management and Prevention of COPD Available from: http://goldcopd.org/gold-reports/Accessed March 20, 2018
Google Scholar
TabbererMLomasDABirkROnce-daily triple therapy in patients with COPD: patient-reported symptoms and quality of lifeAdv Ther2018351567129313286
PubMed Web of Science ®Google Scholar
SinghDMiravitllesMVogelmeierCChronic obstructive pulmonary disease individualized therapy: tailored approach to symptom managementAdv Ther201734228129927981495
PubMed Web of Science ®Google Scholar
AndersonPBenfordMHarrisNKaravaliMPiercyJReal-world physician and patient behaviour across countries: Disease-Specific Programmes–a means to understandCurr Med Res Opin200824113063307218826746
PubMed Web of Science ®Google Scholar
ICC/ESOMARInternational Code on Market and Social Research 2007 Available from: https://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_.pdfAccessed November 7, 2017
Google Scholar
MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)200810534835418453793
PubMed Web of Science ®Google Scholar
MoriskyDEDiMatteoMRImproving the measure of self-reported medication nonadherence: final responseJ Clin Epidemiol2011643258263
Web of Science ®Google Scholar
Krousel-WoodMAIslamTWebberLSReRSMoriskyDEMuntnerPNew medication adherence scale versus pharmacy fill rates in seniors with hypertensionAm J Manag Care2009151596619146365
PubMed Web of Science ®Google Scholar
JonesPWHardingGBerryPDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
PubMed Web of Science ®Google Scholar
WilliamsNThe MRC breathlessness scaleOccup Med (Lond)201767649649728898975
PubMed Web of Science ®Google Scholar
JenkinsCDStantonBANiemcrykSJRoseRMA scale for the estimation of sleep problems in clinical researchJ Clin Epidemiol19884143133213351539
PubMed Web of Science ®Google Scholar
Stata Statistical Software: Release 14College Station, TXStataCorp LP Computer program2015
Google Scholar
GhobadiHAhariSSKameliALariSMThe relationship between COPD Assessment Test (CAT) scores and severity of airflow obstruction in stable COPD patientsTanaffos2012112222625191410
PubMedGoogle Scholar
StentonCThe MRC breathless scaleOccup Med (Lond)200858322622718441368
PubMed Web of Science ®Google Scholar
HenochIStrangSLofdahlCGEkberg-JanssonAHealth-related quality of life in a nationwide cohort of patients with COPD related to other characteristicsEur Clin Respir J201633145927238360
PubMed Web of Science ®Google Scholar
MiravitllesMRiberaAUnderstanding the impact of symptoms on the burden of COPDRespir Res20171816728431503
PubMed Web of Science ®Google Scholar
JoshiMJoshiABartterTSymptom burden in chronic obstructive pulmonary disease and cancerCurr Opin Pulm Med20121829710322262138
PubMed Web of Science ®Google Scholar
DingBDiBonaventuraMKarlssonNBergstromGHolmgrenUA cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness SurveyInt J Chron Obstruct Pulmon Dis20171252953928223793
PubMed Web of Science ®Google Scholar
MiravitllesMWorthHSoler CatalunaJJObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS studyRespir Res20141512225331383
PubMed Web of Science ®Google Scholar
JenkinsCRCelliBAndersonJASeasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyEur Respir J2012391384521737561
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Symptomatic burden of COPD for patients receiving dual or triple therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Symptomatic burden of COPD for patients receiving dual or triple therapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date